Sen. Elizabeth Warren (D-MA) is calling on senior Federal Trade Commission officials to “closely scrutinize” two proposed pharma mergers. Warren expressed concern over “rampant consolidation in the pharmaceutical industry,” in particular Amgen’s $28 billion plans to take over Horizon Therapeutics, and Indivior’s proposed acquisition of Opiant for $145 million upfront, in a letter to FTC Chair Lina Khan and Commissioners Alvaro Bedoya and Rebecca Kelly Slaughter earlier this week.
Read the full article: Sen. Elizabeth Warren Urges FTC to ‘Scrutinize’ Two Pharma Buyouts //
Source: https://endpts.com/sen-elizabeth-warren-urges-ftc-to-scrutinize-two-pharma-buyouts